Navigation Links
PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
Date:7/16/2008

tions and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 63 locations throughout 52 countries around the world, and has more than 7,600 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependenc
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
2. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
3. PAREXEL Expands Global Clinical Logistics Capabilities
4. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
5. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
6. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
7. PAREXEL Reaches Agreement To Acquire ClinPhone
8. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
9. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
10. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
11. PAREXEL Reports Third Quarter Fiscal Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 In preparation for VARTECH ... -based cybersecurity company focused on authentication and SSO announced ... the ability to generate a OTP through the presentation ... pioneer of user-based RFID authentication, 2FA,s solutions have leveraged ... for many years. RFID authentication is broadly deployed in ...
(Date:9/16/2014)... Australia (PRWEB) September 16, 2014 RENU 28, ... Signaling molecules, became available for purchase in Australia and ... a nationwide tour beginning September 16th. The tour will make ... the 17th, Bundaberg on the 18th, Sydney on the 20th, ... market in Australia and New Zealand and to educate people ...
(Date:9/15/2014)... States (PRWEB) September 16, 2014 ... Cancer Vaccines, and Adoptive T-cell Therapies is a ... report focuses on the three principal types of ... research and development in cancer immunotherapy (which is ... Therapeutic anticancer vaccines and Adoptive cellular immunotherapy. ...
(Date:9/15/2014)... University have developed a technique for controlling the surface ... opening the door to a new generation of reconfigurable ... on the fact that the oxide "skin" of the ... acts as a surfactant, lowering the surface tension between ... used a liquid metal alloy of gallium and indium. ...
Breaking Biology Technology:2FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Wellness Company Hosts ASEA Australia Tour September 16-22 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Researchers control surface tension to manipulate liquid metals 2
... SOUTH SAN FRANCISCO, Calif., June 11 iZumi ... industrialization of induced pluripotent stem cell (iPS) technology ... cellular reprogramming and directed differentiation of patient cells, ... Ph.D., to the company,s board of directors and ...
... Calif., June 11 STAAR Surgical Company (Nasdaq: ... of minimally invasive ophthalmic products, today announced that the ... System for use with the Affinity(TM) Collamer(R) Three-Piece NTIOL ... Epiphany will usher in a new era of insertion ...
... WALTHAM, Mass., June 11 Repligen Corporation (Nasdaq: ... fiscal year 2009, ended March 31, 2009. Total revenue ... of $19,296,000 for fiscal year 2008 ended March 31, 2008, ... the year was comprised of Protein A product revenue, and ...
Cached Biology Technology:iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board 2iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board 3STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System 2STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System 3Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 2Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 3Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 4Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 5Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 6Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 7
(Date:9/16/2014)... make ethical choices such as buying clothing not made ... coffee, and bringing their own bags when they go ... Journal of Consumer Research , ethical consumption is motivated ... about unethical practices into action. , "Advocates of ethical ... human costs of the products they choose, but unfortunately ...
(Date:9/16/2014)... N.C. , Sept. 16, 2014  Valencell, Inc., ... been chosen as one of 18 "Showcase Companies" representing ... businesses at the annual CED Tech Venture Conference on ... Convention Center in Raleigh, North ... will lead a discussion during the "Digital Health ...
(Date:9/16/2014)... a season of bounty. Fungi of dizzying variety erupt ... in search of elusive but delectable wild mushrooms. Part ... treasure hunt, and their mysterious not-quite-meat, not-quite-vegetable qualities that ... which you are eating known to science? , The ... although some estimates range up to 10 million species, ...
Breaking Biology News(10 mins):Why are consumers willing to spend more money on ethical products? 2Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 3
... disease are increasingly becoming resistant to synthetic insecticides. Now ... Complementary and Alternative Medicine suggests that the berries of ... have potential for keeping mosquitoes at bay. S. ... for its medicinal properties and commonly used as ...
... Southern Research Station (SRS), Iowa State University, and the ... of a fungus responsible for the wilt of redbay ... Florida. In the February issue of Plant Disease, ... results from their assessment of the fungus, the beetle ...
... but the microscopic animals called bdelloid rotifers seem to get ... have done so over millions of years of evolution, resulting ... the usual drawback of asexuality extinction and the ... finding out how. In two related papers published ...
Cached Biology News:Ayurvedic nightshade deadly for dengue mosquito 2Laurel wilt of redbay and sassafras: Will avocados be next? 2Is DNA repair a substitute for sex? 2Is DNA repair a substitute for sex? 3
... for use as a wash buffer for Michels ... is useful for transportation of specimens (such as ... Samples may remain in Transport Fluid for ... Michels Transport Fluid is not a fixative and ...
... use with 96- or 384-well PCR plates Dimples ... location on 96-tube plates End tabs on Thermo-Mat™ ... plate* Efficient sealing is achieved with either Thermo-Mat™ ... or clip-down hot lid thermal cyclers Fully autoclavable ...
... TUNEL-based assay kit provides complete components including ... detection of DNA fragmentation in cultured cells ... in the procedure provides greater sensitivity than ... analyzed by flow cytometry. The kit works ...
... Buffer is a unique alternative to ... (TRIS acetate-EDTA) electrophoresis buffers. Bionic Buffer ... rapid running times, and high-resolution band ... gel electrophoresis after dilution to working ...
Biology Products: